Your browser doesn't support javascript.
loading
Repeated COVID-19 relapse during post-discharge surveillance with viral shedding lasting for 67 days in a recovered patient infected with SARS-CoV-2.
Liu, Fang; Cai, Zhao-Bin; Huang, Jin-Song; Niu, Hai-Ying; Yu, Wen-Yan; Zhang, Yan; Yan, Ting-Bo; Chen, Chen; Liu, Yuan; Xu, Ai-Fang.
Afiliación
  • Liu F; Medical Laboratory, Xixi Hospital of Hangzhou, Hangzhou, China.
  • Cai ZB; Department of Infectious Disease, Xixi Hospital of Hangzhou, Hangzhou, China.
  • Huang JS; Department of Infectious Disease, Xixi Hospital of Hangzhou, Hangzhou, China.
  • Niu HY; Medical Laboratory, Xixi Hospital of Hangzhou, Hangzhou, China.
  • Yu WY; Medical Laboratory, Xixi Hospital of Hangzhou, Hangzhou, China.
  • Zhang Y; Medical Laboratory, Xixi Hospital of Hangzhou, Hangzhou, China.
  • Yan TB; Department of Radiology, Xixi Hospital of Hangzhou, Hangzhou, China.
  • Chen C; Department of Neuroscience, Temple University, Philadelphia, PA, USA.
  • Liu Y; Medical Laboratory, Xixi Hospital of Hangzhou, Hangzhou, China.
  • Xu AF; Medical Laboratory, Xixi Hospital of Hangzhou, Hangzhou, China. Electronic address: xuaifangjyk@163.com.
J Microbiol Immunol Infect ; 54(1): 101-104, 2021 Feb.
Article en En | MEDLINE | ID: mdl-32807688
A case who revealed the longest duration of viral shedding (67 days) in current reports, presented complicated characteristic on the relapse of COVID-19 due to the inconsistent performance of chest radiography and SARS-CoV-2-RNA detection after discharge. Lopinavir-interferon α2b boosted ribavirin following with lopinavir boosted budesonide might be a potent treatment for viral clearance.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: SARS-CoV-2 / COVID-19 Tipo de estudio: Prognostic_studies / Screening_studies Límite: Female / Humans / Middle aged Idioma: En Revista: J Microbiol Immunol Infect Asunto de la revista: ALERGIA E IMUNOLOGIA / MICROBIOLOGIA Año: 2021 Tipo del documento: Article País de afiliación: China Pais de publicación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: SARS-CoV-2 / COVID-19 Tipo de estudio: Prognostic_studies / Screening_studies Límite: Female / Humans / Middle aged Idioma: En Revista: J Microbiol Immunol Infect Asunto de la revista: ALERGIA E IMUNOLOGIA / MICROBIOLOGIA Año: 2021 Tipo del documento: Article País de afiliación: China Pais de publicación: Reino Unido